• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov18
Yaoke Technology sees significant increase in per share net assets in Q3, secretary explains reasons
11:01
Nov5
Yaojie Health Care Grants Global Development Rights to NLRP3 Inhibitor for $881.5 Million
12:17
Nov3
Jiangke-B Enters into NLRP3 Inhibitor Collaboration Agreement with Neurocrine
00:19
Sep10
Yj-Ak-B's Core Product Combination Therapy Receives NMPA Conditional Clinical Approval
13:55
Aug25
TRANSTHERA-B released FY2025 Q2 earnings on August 25, 2025 (BJT) with actual revenue of HKD 0 and EPS of HKD -0.1759
15:00
TRANSTHERA-B released FY2025 Semi-Annual Earnings on August 25, 2025 (BJT) with actual revenue of HKD 0 and EPS of HKD -0.348
15:00

Schedules & Filings

Schedules
Filings
Aug25
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Net Income -67.24 M, EPS -0.1759

Jun23
IPO(CST)

Listing Price HKD 13.15

Jun9
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Net Income -60.76 M, EPS -0.1592

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08583
0.090
+104.55%
+0.046
01172
0.034
+47.83%
+0.011
02906
0.260
+30.00%
+0.060
00756
0.660
+29.41%
+0.150
07311
14.860
+28.21%
+3.270
01201
1.000
+28.21%
+0.220
07399
75.260
+27.26%
+16.120
09311
1.898
+26.87%
+0.402
09399
9.635
+26.86%
+2.040
00648
0.260
+23.81%
+0.050
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy